Gerrit

23 Added | 2 Magazines | 17 Followers | @gbrinkhaus | Keep up with Gerrit on Flipboard, a place to see the stories, photos, and updates that matter to you. Flipboard creates a personalized magazine full of everything, from world news to life’s great moments. Download Flipboard for free and search for “Gerrit”

Pfizer (PFE) Profit Expected to Slip

Analysts foresee <b>Pfizer</b> announcing decreased profits on Tuesday, July 30, 2013, when it reports its second quarter earnings. Despite this, they are generally optimistic about the stock.<p>Analysts are projecting Pfizerto come in with earnings of 54 cents per share, 13% less than a year ago when it …

Taking on Goliath-Jim Dotson Author interview: What is this book about?

Earnings Preview: Pfizer to report on new drugs

TRENTON, N.J. (AP) -- Pfizer Inc. will update analysts on progress on its experimental drugs, particularly its growing cancer medicine franchise, and …

Biotechnology

InPlay Article

Co issued the following statement regarding the conclusion of the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use …

FDA Just Approved A Breakthrough Merck Drug That Treats Diabetes And Cholesterol

The Food and Drug Administration approved the drug Juvisync, which combines Merck's diabetes pill Januvia with the popular cholesterol drug Zocor.<p>Patients with both diabetes and high cholesterol are at increased risk for heart disease, stroke, kidney disease and other chronic conditions.<p>The …

Diabetes

Merck Is Taking A Huge Risk By Betting On An Alzheimer's Treatment

The competition for the next big drug is incredibly fierce. Perhaps the biggest potential blockbusters of all is a treatment to slow down Alzheimer's. It's the number 6 killer in the United States, yet there isn't a drug that truly slows mental decline.<p>The drugs we have can only temporarily …

Biotechnology

Mercks Sparprogramm greift

<b>Der Pharma- und Spezialchemiekonzern Merck profitiert von seinen Sparanstrengungen und höheren Medikamentenpreisen. Die Dividende soll steigen.</b><p>Der …

Pharmakonzern: Gewinn von Merck schrumpft

Merck-Chef Karl-Ludwig Kley drückt bei dem Pharmakonzern auf die Kosten.<p>(Foto: dapd)<p>Merck baute 2012 seine Gesamterlöse zwar um 8,7 Prozent auf 11,2 …

Facebook

[09.02.2018] Höhere Kosten, vor allem aber hohe Einmalabschreibungen auf Vermögenswerte haben bei dem US-Hersteller Allergan 2017 ein tiefes Loch in …

Merck Becomes #28 Most Shorted Dow Stock, Replacing JPMorgan

The most recent short interest data has been released by the NASDAQ for the 03/28/2013 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by “days to cover.” There are a number of ways to look …

Merck Could Return To Greatness If CEO Can Leave His Own Past Behind

About nine months before Ken Frazier took over as chief executive of Merck in January 2011, he made a pilgrimage to see his old boss: P. Roy Vagelos. When Vagelos ran Merck it was the largest drug company on the planet, an innovative giant that created modern cholesterol drugs, blood pressure pills …

Merck Softens A Lower 2013 Profit Forecast With $15B Stock Buyback

Merck hopes to soothe the pain of a lowered full-year profit forecast with a massive stock buyback program.<p>Merck now expects to earn between $3.45 to $3.55 a share. That’s below the $3.60 to $3.70 a share it forecast in February. Analysts already predicted Merck could book $3.62 a share.<p>Like other …

HPV Vaccine Prices Drop To Reach Girls In The Developing World

Of the 270,000 annual deaths from cervical cancer, 85% happen in the developing world, where Pap smears and viral DNA testing are not available to catch cancer or pre-cancer early.<p>Cervical cancer is caused by a virus — certain strains of the human papilloma virus — and two vaccines exist to prevent …

Bullish Options Traders Bet On Oracle Rebound, Make Tracks For Merck Calls

Today’s tickers: ORCL, MRK & WCG<p><b>ORCL – Oracle Corp. –</b> Shares in software company, Oracle Corp., are getting crushed today, down as much as 9.5% to a seven-month low of $30.06, after the company reported fourth-quarter sales that missed estimates for a second consecutive quarter. The sharp move in …